Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Challenges in neoantigen-directed therapeutics
Lien Lybaert, Steve Lefever, Bruno Fant, et al.
Cancer Cell (2022) Vol. 41, Iss. 1, pp. 15-40
Open Access | Times Cited: 70

Showing 26-50 of 70 citing articles:

Unveiling the immunological landscape: comprehensive characterization of neoantigen-reactive immune cells in neoantigen cancer vaccines
Weijiang Liu, Hong Su, Peng Guo, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Comprehensive Analysis of MAGE-A10 in Pan-Cancer and Its Validation in Gastric Cancer
Yichen Yin, Baozhen Wang, Mingzhe Yang, et al.
Research Square (Research Square) (2025)
Closed Access
TCR sequencing: applications in immuno-oncology research
Ángel Fernández Sanromán, Kroopa Joshi, Lewis Au, et al.
Immuno-Oncology Technology (2023) Vol. 17, pp. 100373-100373
Open Access | Times Cited: 11
Neoantigen cancer vaccines: a new star on the horizon
Xiaoling Li, Jian You, Liping Hong, et al.
Cancer Biology and Medicine (2023), pp. 1-38
Open Access | Times Cited: 11
A functional identification platform reveals frequent, spontaneous neoantigen-specific T cell responses in patients with cancer
Aaron M. Miller, Zeynep Koşaloğlu, Luise Westernberg, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 736
Open Access | Times Cited: 3
Novel insights into TCR-T cell therapy in solid neoplasms: optimizing adoptive immunotherapy
Weihuan Shao, Yiran Yao, Ludi Yang, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Colorectal Cancer Immunotherapy: State of the Art and Future Directions
Alyssa Mauri Cornista, Maria Virginia Giolito, Kristi Baker, et al.
Gastro Hep Advances (2023) Vol. 2, Iss. 8, pp. 1103-1119
Open Access | Times Cited: 9
Targeting Tumor Heterogeneity with Neoantigen-Based Cancer Vaccines
Saranya Pounraj, Shuxiong Chen, Linlin Ma, et al.
Cancer Research (2023) Vol. 84, Iss. 3, pp. 353-363
Closed Access | Times Cited: 9
Are we getting closer to a successful neoantigen cancer vaccine?
Karen Manoutcharian, Goar Gevorkian
Molecular Aspects of Medicine (2024) Vol. 96, pp. 101254-101254
Closed Access | Times Cited: 3
Old concepts, new tricks: How peptide vaccines are reshaping cancer immunotherapy?
Qingyang Liu, Peihua Wu, Jun Lei, et al.
International Journal of Biological Macromolecules (2024) Vol. 279, pp. 135541-135541
Closed Access | Times Cited: 3
The peptide woods are lovely, dark and deep: Hunting for novel cancer antigens
Daniel Oreper, Susan Klaeger, Suchit Jhunjhunwala, et al.
Seminars in Immunology (2023) Vol. 67, pp. 101758-101758
Closed Access | Times Cited: 7
Relevance of mutation-derived neoantigens and non-classical antigens for anticancer therapies
Belén Aparicio, Patrick Theunissen, Sandra Hervás‐Stubbs, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 2
Epigenetic therapy potentiates transposable element transcription to create tumor-enriched antigens in glioblastoma cells
H. Josh Jang, Nakul M. Shah, Ju Heon Maeng, et al.
Nature Genetics (2024) Vol. 56, Iss. 9, pp. 1903-1913
Closed Access | Times Cited: 2
Identification of immunogenic HLA class I and II neoantigens using surrogate immunopeptidomes
Serina Tokita, Minami Fusagawa, Satoru Matsumoto, et al.
Science Advances (2024) Vol. 10, Iss. 38
Open Access | Times Cited: 2
Leveraging a powerful allogeneic dendritic cell line towards neoantigen-based cancer vaccines
Dalil Hannani, Estelle Leplus, Karine Laulagnier, et al.
Genes & Cancer (2023) Vol. 14, pp. 3-11
Open Access | Times Cited: 4
Precise diagnosis and treatment for peripheral T-cell lymphomas: From pathogenic mechanisms to innovative approaches
Yuran Qiu, Weili Zhao
The Innovation Medicine (2024) Vol. 2, Iss. 1, pp. 100048-100048
Open Access | Times Cited: 1
Untranslated regions (UTRs) are a potential novel source of neoantigens for personalised immunotherapy
Christopher C.T. Sng, Ashwin Adrian Kallor, Benjamin S. Simpson, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Current status and progress of research on the ADP-dependent glucokinase gene
Ningjing Guo, Qiong Luo, Qixian Zheng, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Integrating Reinforcement Learning and Monte Carlo Tree Search for enhanced neoantigen vaccine design
Yicheng Lin, Jiakang Ma, Haozhe Yuan, et al.
Briefings in Bioinformatics (2024) Vol. 25, Iss. 3
Open Access | Times Cited: 1
Tumor‐Associated Myeloid Cells Selective Delivery of a Therapeutic Tumor Nano‐Vaccine for Overcoming Immune Barriers for Effective and Long‐Term Cancer Immunotherapy
Chufan Wang, Jinglian Zhao, yufei Duan, et al.
Advanced Healthcare Materials (2024)
Closed Access | Times Cited: 1
Development and Clinical Applications of Therapeutic Cancer Vaccines with Individualized and Shared Neoantigens
Qing Hao, Yuhang Long, Yi Yang, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 717-717
Open Access | Times Cited: 1
Altered epitopes enhance macrophage‐mediated anti‐tumour immunity to low‐immunogenic tumour mutations
Qiumin Yu, Tingran Zhang, Tiandi He, et al.
Immunology (2024) Vol. 173, Iss. 4, pp. 654-671
Closed Access | Times Cited: 1
Recombinant ferritin-based nanoparticles as neoantigen carriers significantly inhibit tumor growth and metastasis
Wei Zheng, Shixiong Li, Zhongliang Shi, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
TIL Therapy in Lung Cancer: Current Progress and Perspectives
Weilei Hu, Y. Bian, Hongbin Ji
Advanced Science (2024)
Open Access | Times Cited: 1
Driver mutation landscape of acute myeloid leukemia provides insights for neoantigen-based immunotherapy
Peng Jin, Jie Shen, Ming Zhao, et al.
Cancer Letters (2024) Vol. 611, pp. 217427-217427
Open Access | Times Cited: 1

Scroll to top